Avid Bioservices Inc (CDMO)

[freethemice]

Lately I have been wondering about the timing of the release of trial results. I think Peregrine has enough latitude here to present data as they like. They can always just let the data "mature" more until the timing suits them. So, I have been wondering if there would be an advantage to announcing the updated results from the second-line NSCLC trial and the MOS for the first-line NSCLC and pancreatic trial together. Say, around the first of March. Maybe it would depend on whether or not there is a partner all signed up and ready to go. Which way would the partner prefer this to happen? If there is no partner by then would announcing all at once be preferred over spreading things out over a month or so?